CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.

J Immunother Cancer · 2023 · PMC10711923 · PMID 38056897

Europe PMC DOI

hedged sentence

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

marginally significantp=0.081so close (0.05 < p ≤ 0.1)

Survival analysis ( figure 3F ) showed an improvement in survival for mice in the CXCL10-Nrf2-FTH-MSC group (median survival time: 21 days) compared to the PBS group (median survival time: 15 days), with a marginally significant difference (p=0.081).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.